You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

non-transfusion dependent

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non-transfusion-dependent Thalassemia, Low Risk Myelodysplastic Syndrome, Very-Low Risk Myelodysplastic Syndrome Trial in

Recruiting
  • Non-transfusion-dependent Thalassemia
  • +2 more
  • Düsseldorf, Germany
  • +19 more
Mar 18, 2022

Major Perioperative Allogeneic Blood Requirements in Cardiac

Completed
  • Transfusion-dependent Anemia
  • Massive Transfusion of Allogeneic Blood
  • Linz, Upper Austria, Austria
    Kepler University Hospital
Nov 22, 2022

Anemia Trial (Luspatercept)

Not yet recruiting
  • Anemia
  • Luspatercept
  • (no location specified)
May 26, 2023

Prospective Study on Feto-maternal outcoMe In aNemIc womEn

Active, not recruiting
  • Anemia
  • +6 more
  • iron deficiency, coagulation abnormalities
  • San Giovanni Rotondo, Foggia, Italy
  • +1 more
Feb 20, 2023

Beta-Thalassemia Trial in China (BRL-101)

Recruiting
  • Beta-Thalassemia
  • Guangzhou, Guangdong, China
  • +3 more
Nov 7, 2022

Aplastic Anemia, Drug Effect Trial in Beijing (Herombopag + CsA, rhTPO combined with Herombopag + CsA)

Not yet recruiting
  • Aplastic Anemia
  • Drug Effect
  • Herombopag + CsA
  • rhTPO combined with Herombopag + CsA
  • Beijing, China
    Peking union medical college hospital
Aug 16, 2023

Thalassemia, Beta, Thalassemia Major Trial in Tianjin (VGB-Ex01)

Not yet recruiting
  • Thalassemia, Beta
  • Thalassemia Major
  • VGB-Ex01
  • Tianjin, Tianjin, China
    Regenerative Medicine Center
Sep 11, 2023

MDS Trial (Imetelstat)

Available
  • Myelodysplastic Syndromes
  • (no location specified)
Jun 30, 2023

Aplastic Anemia Trial in Beijing (Luspatercept)

Not yet recruiting
  • Aplastic Anemia
  • Beijing, China
    Peking union medical college hospital
May 30, 2022

Beta Thalassaemia Trial in Milan (Safety and Efficacy assessments)

Active, not recruiting
  • Beta Thalassaemia
  • Safety and Efficacy assessments
  • Milan, Italy
    Ospedale San Raffaele - Telethon Institute for Gene Therapy (OSR
Nov 22, 2022

Non-transfusion-dependent Thalassemia, Low Risk Myelodysplastic Syndrome Trial in Bulgaria, United Kingdom (SLN124 is a GalNAc

Withdrawn
  • Non-transfusion-dependent Thalassemia
  • Low Risk Myelodysplastic Syndrome
  • SLN124 is a GalNAc conjugated double stranded fully modified siRNA. Sodium chloride 0.9% w/v is used as Placebo
  • Kyustendil, Bulgaria
  • +4 more
Apr 23, 2020

Transfusion Dependent Beta-Thalassaemia Trial in Guangzhou, Shenzhen, Tianjin (ET-01)

Active, not recruiting
  • Transfusion Dependent Beta-Thalassaemia
  • ET-01
  • Guangzhou, Guangdong, China
  • +3 more
May 9, 2022

After Ex-vivo Gene Therapy With BIVV003 in Severe Sickle Cell

Recruiting
  • Blood and Lymphatic Diseases
  • Detroit, Michigan
    Investigational Site Number :8400001
Jul 6, 2022

Beta-Thalassemia, Thalassemia, Hematologic Diseases Trial (CTX001)

Not yet recruiting
  • Beta-Thalassemia
  • +6 more
  • CTX001
  • (no location specified)
Jul 26, 2022

MDS Trial in Worldwide (Talacotuzumab, Daratumumab)

Completed
Has Results
  • Myelodysplastic Syndromes
  • Saint Louis, Missouri
  • +20 more
Dec 28, 2022

Beta-Thalassemia, Thalassemia, Genetic Diseases, Inborn Trial in Nashville (CTX001)

Recruiting
  • Beta-Thalassemia
  • +4 more
  • CTX001
  • Nashville, Tennessee
  • +5 more
Feb 2, 2023

Transfusion Dependent Beta-Thalassaemia Trial in Tianjin (ET-01)

Active, not recruiting
  • Transfusion Dependent Beta-Thalassaemia
  • ET-01
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Dec 9, 2021

Transfusion Dependent Beta-thalassemia Trial in United States (ST-400 Investigational product)

Active, not recruiting
  • Transfusion Dependent Beta-thalassemia
  • ST-400 Investigational product
  • Los Angeles, California
  • +5 more
Jul 6, 2022

Beta-Thalassemia Trial in Bulgaria, Israel, United States (VIT-2763 60 mg QD, VIT-2763 60 mg BID, VIT-2763 120 mg BID)

Withdrawn
  • Beta-Thalassemia
  • VIT-2763 60 mg QD
  • +3 more
  • Whittier, California
  • +6 more
Nov 7, 2022

Stroke, Aging Trial in Geneva (Non-invasive brain stimulation)

Completed
  • Stroke
  • Aging
  • Non-invasive brain stimulation
  • Geneva, Switzerland
    Campus Biotech
Apr 24, 2023

Beta-Thalassemia, Thalassemia, Genetic Diseases, Inborn Trial in Worldwide (CTX001)

Active, not recruiting
  • Beta-Thalassemia
  • +4 more
  • CTX001
  • Stanford, California
  • +11 more
Nov 30, 2022

MDS Trial in Worldwide (Luspatercept, Epoetin Alfa)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Luspatercept
  • Epoetin Alfa
  • Concord, California
  • +100 more
Jul 20, 2023

Thalassemia, Iron Overload Trial in Nanning (CN128 Tablets)

Active, not recruiting
  • Thalassemia
  • Iron Overload
  • CN128 Tablets
  • Nanning, Guangxi, China
    The First Affiliated Hospital Of Guangxi Medical University
Aug 3, 2022

Diabetes, Diabete Type 2 Trial in Reno (Dayamed Arthur a novel intelligent medication adherence platform)

Completed
  • Diabetes
  • Diabete Type 2
  • Dayamed Arthur a novel intelligent medication adherence platform
  • Reno, Nevada
    VA Sierra Nevada Health Care System
Mar 15, 2023

d Blood Loss, Blood Transfusion, and Postoperative Clinical

Recruiting
  • General Surgery
  • Blood Loss, Surgical
  • observational study
  • Bangkok, Thailand
    Siriraj hospital
Jul 14, 2022